On the validity of using increases in 5-year survival rates to measure success in the fight against cancer

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Maruvka, Yosef E ^a,b   Tang, Min ^a,b   Michor, Franziska ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DENMARK; EARLY DIAGNOSIS; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NORWAY; POPULATION RESEARCH; SURVIVAL RATE; SWEDEN; UNITED STATES; VALIDITY; DISEASE FREE SURVIVAL; INCIDENCE; MASS SCREENING; MORTALITY; NEOPLASMS; OUTCOME ASSESSMENT; PROCEDURES; REGISTER; SURVIVAL;

DISEASE-FREE SURVIVAL; HUMANS; INCIDENCE; MASS SCREENING; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84904610334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083100     Document Type: Article

References (14)

1. Duarte-Franco E, Franco EL (2001) Determinants of patient survival in cervical cancer: an overview. CME J Gynecol Oncol, 6: 173-183. (Pubitemid 32979402)
2. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, et al. (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Journal of the National Cancer Institute. 93(11): 824-842. (Pubitemid 32586611)
3. Davis FG, Freels S, Grutsch J, Barlas S, Brem S (1998) Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. Journal of Neurosurgery. 88(1): 1-10.
4. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, et al. (2007) Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncology. 8(9): 784-796. (Pubitemid 47321601)
5. Cancer survivorship [press release] (1999) U.D.o.H.a.H. Services, Editor. August 12: Washington, DC:.
6. Sondik EJ (1990) MEASUREMENT OF PROGRESS AGAINST CANCER. Journal of the National Cancer Institute. 82(10): 825-835.
7. Welch HG, Schwartz LM, Woloshin S (2000) Are increasing 5-year survival rates evidence of success against cancer? Jama-Journal of the American Medical Association. 283(22): 2975-2978. (Pubitemid 30414510)
8. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T (2001) Nasal and paranasal sinus carcinoma: Are we making progress? A series of 220 patients and a systematic review. Cancer. 92(12): 3012-3029. (Pubitemid 33136196)
9. Weinberg RA (2007) The biology of cancer. Vol. 255.: Garland Science New York.
10. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2010 Sub (1973-2008) 〈Single Ages to 85+, Katrina/Rita Population Adjustment〉 - Linked To County Attributes - Total U.S., 1969-2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011 (updated 10/28/2011), based on the November 2010 submission ed.
11. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, et al. (2010) NORDCAN - a Nordic tool for cancer information, planning, quality control and research. Acta Oncologica. 49(5): 725-736.
12. Welch HG, Black WC (2010) Overdiagnosis in Cancer. Journal of the National Cancer Institute. 102(9): 605-613.
13. Henson DE, Siddiqui H, Schwartz AM (2010) Re: Overdiagnosis in Cancer. Journal of the National Cancer Institute. 102(23): 1809-1810.
14. Asadzadeh Vostakolaei F, Karim-Kos HE, Janssen-Heijnen ML, Visser O, Verbeek AL, et al. (2011) The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. The European Journal of Public Health. 21(5): 573-577.